ScienceDex / Researcher record
Donald W. Kufe
- Dana-Farber Cancer Institute (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
FY2024 NIH rank #1,910
- R01 Holder
- Top 10% Funded
- Early Career
- Diverse Portfolio
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $3,622,310 | 4 | #1,910 |
| 2025 | $3,404,421 | 4 | #2,725 |
| 2026 | $3,395,294 | 3 | #5,216 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected4 records
- FY20254 records
- FY20263 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1898917Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0001-5743-8888Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Internal Medicine
FY2024 award records by amount
NIH award records listing Donald W. Kufe as a PI. Multi-PI records show the full award amount for context.
- 5UM1CA186709-08UM1Co-investigatorDana-Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site)$2Maward amount
- 1R01CA282437-01A1R01Co-investigatorCombining CDK7 and MUC1-C inhibition to target different subtypes of small cell lung cancerNYU Grossman School of Medicine · Internal Medicine (NIH department code)$735Kaward amount
- 2R01CA097098-20A1R01Contact PITargeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer$466.6Kaward amount
- 1R21CA289134-01R21Contact PIMUC1-C is a target for advancing immunotherapy of non-small cell lung cancer$450.4Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Donald W. Kufe as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardDana-Farber Cancer Institute
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1910
- 2024Entered Top 25% NationallyRanked #1910
- 2024Entered Top 10% NationallyRanked #1910
- 2025$5M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2026$10M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Donald W. Kufe.